[go: up one dir, main page]

ZA200203435B - Method and compositions for treating pulmonary diseases. - Google Patents

Method and compositions for treating pulmonary diseases.

Info

Publication number
ZA200203435B
ZA200203435B ZA200203435A ZA200203435A ZA200203435B ZA 200203435 B ZA200203435 B ZA 200203435B ZA 200203435 A ZA200203435 A ZA 200203435A ZA 200203435 A ZA200203435 A ZA 200203435A ZA 200203435 B ZA200203435 B ZA 200203435B
Authority
ZA
South Africa
Prior art keywords
compositions
pulmonary diseases
treating pulmonary
treating
diseases
Prior art date
Application number
ZA200203435A
Inventor
Peter N Goodfellow
Richard Nieman
Theodore J Torphy
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA200203435B publication Critical patent/ZA200203435B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200203435A 1999-11-02 2002-04-30 Method and compositions for treating pulmonary diseases. ZA200203435B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02

Publications (1)

Publication Number Publication Date
ZA200203435B true ZA200203435B (en) 2003-06-25

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200203435A ZA200203435B (en) 1999-11-02 2002-04-30 Method and compositions for treating pulmonary diseases.

Country Status (29)

Country Link
EP (1) EP1225866A4 (en)
JP (1) JP2003513028A (en)
KR (1) KR20020057988A (en)
CN (1) CN1387404A (en)
AP (1) AP2002002496A0 (en)
AR (1) AR029189A1 (en)
AU (1) AU1357501A (en)
BG (1) BG106748A (en)
BR (1) BR0015270A (en)
CA (1) CA2388333A1 (en)
CO (1) CO5261512A1 (en)
CZ (1) CZ20021512A3 (en)
DZ (1) DZ3225A1 (en)
EA (1) EA200200518A1 (en)
EC (1) ECSP003747A (en)
HK (1) HK1049107A1 (en)
HU (1) HUP0203152A3 (en)
IL (1) IL149367A0 (en)
MA (1) MA26841A1 (en)
MX (1) MXPA02004350A (en)
NO (1) NO20022057L (en)
OA (1) OA12076A (en)
PE (1) PE20011005A1 (en)
PL (1) PL355261A1 (en)
SK (1) SK7592002A3 (en)
TR (1) TR200201211T2 (en)
TW (1) TWI242431B (en)
WO (1) WO2001032127A2 (en)
ZA (1) ZA200203435B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE355080T1 (en) * 2001-09-19 2006-03-15 Altana Pharma Ag COMBINATION OF AN NSAIDS AND A PDE-4 INHIBITOR
CA2462525A1 (en) * 2001-10-31 2003-05-08 Merck Patent Gesellschaft Mit Beschraenkter Haftung Type 4 phosphodiesterase inhibitors and uses thereof
UA82323C2 (en) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Novel combination of a glucocorticoid and pde-inhibitor for the treatment of respiratory diseases, allergic diseases, asthma and chronic obstructive pulmonary diseases
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
JPWO2004087149A1 (en) * 2003-03-31 2006-06-29 協和醗酵工業株式会社 Pharmaceutical composition
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
WO2006041121A1 (en) * 2004-10-13 2006-04-20 Kyowa Hakko Kogyo Co., Ltd. Remedies/preventives for chronic skin disease
US20090054382A1 (en) * 2005-10-19 2009-02-26 Abhijit Ray Compositions of phosphodiesterase type iv inhibitors
CN105381524A (en) 2010-01-05 2016-03-09 微剂量治疗技术公司 Inhalation device and method
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7174794A (en) * 1993-06-18 1995-01-17 Smithkline Beecham Corporation Compounds
DE4332041C2 (en) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Use of pentoxifylline in certain lung diseases
PE44995A1 (en) * 1994-01-27 1995-12-18 Schering Corp MOMETASONE FUROATE FOR THE TREATMENT OF LUNG DISEASES AND RESPIRATORY TRACT
SE9801368D0 (en) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
KR20020057988A (en) 2002-07-12
WO2001032127A2 (en) 2001-05-10
AP2002002496A0 (en) 2002-06-30
JP2003513028A (en) 2003-04-08
SK7592002A3 (en) 2002-11-06
MXPA02004350A (en) 2002-11-07
TR200201211T2 (en) 2002-08-21
PL355261A1 (en) 2004-04-05
BR0015270A (en) 2002-06-18
DZ3225A1 (en) 2001-05-10
CA2388333A1 (en) 2001-05-10
MA26841A1 (en) 2004-12-20
NO20022057L (en) 2002-06-27
EP1225866A2 (en) 2002-07-31
EP1225866A4 (en) 2004-04-21
OA12076A (en) 2006-05-04
AR029189A1 (en) 2003-06-18
BG106748A (en) 2003-02-28
IL149367A0 (en) 2002-11-10
HUP0203152A2 (en) 2003-01-28
WO2001032127A3 (en) 2001-12-06
PE20011005A1 (en) 2001-09-28
CO5261512A1 (en) 2003-03-31
HK1049107A1 (en) 2003-05-02
AU1357501A (en) 2001-05-14
CZ20021512A3 (en) 2003-04-16
CN1387404A (en) 2002-12-25
TWI242431B (en) 2005-11-01
NO20022057D0 (en) 2002-04-30
EA200200518A1 (en) 2002-10-31
ECSP003747A (en) 2002-05-23
HUP0203152A3 (en) 2004-06-28

Similar Documents

Publication Publication Date Title
EP1128832A4 (en) Compounds, compositions and methods for treating or preventing viral infections and associated diseases
MXPA01011334A (en) Detergent composition and method for removing soil.
ZA200106160B (en) Compositions and methods for treating cataracts.
AU5294100A (en) Method and compositions for treating the inflammatory response
ZA200108446B (en) Novel method of treatment.
AP2000002010A0 (en) Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
IL144561A0 (en) Liposome compositions and methods for treating pests utilizing the same
AU2002367023A8 (en) Compositions and methods for treating heart failure
MX246293B (en) Compositions and methods for treating hyperpigmentation.
HU0001629D0 (en) Method for treating plants and compositions for it
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
MXPA01011923A (en) Compositions and methods for treating cell proliferation disorders.
AU2002365057A8 (en) Compositions and methods for treating heart failure
ZA200203435B (en) Method and compositions for treating pulmonary diseases.
ZA200206252B (en) Method and compositions for treating an inflammatory disease.
EP1234869A4 (en) Cleaning composition and method for preparing the same
AU4515001A (en) Compositions and methods for locally treating inflammatory diseases
MXPA03004017A (en) Method for the treatment of inflammation.
AU6137801A (en) Method and composition for the treatment of angiogenesis
ZA200002546B (en) Sorbate-preserved compositions, method for the manufacture thereof and their use.
AU2001238288A1 (en) Method and compositions for treating fibrotic diseases
GB9904765D0 (en) Plant treatment method
GB0026838D0 (en) Treatment method
ZA200007396B (en) Method of treatment.
AU2002342188A8 (en) Methods and compositions for treating flavivirus-mediated disease